Prostatic-specific Antigen Velocity After Holmium Laser Enucleation of the Prostate: Possible Predictor for the Assessment of Treatment Effect Durability for Benign Prostatic Hyperplasia and Detection of Malignancy
Authors:
- Ehab A. ElzayatEEEhab A. Elzayat
- John S. SampalisJSJohn S. Sampalis
- Mostafa M. ElhilaliMEMostafa M. Elhilali
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Holmium Laser Enucleation of Prostate in Patients With Prostate Size ≤60 cm3Urology, 2009
- Holmium Laser Enucleation of the Prostate versus Open Prostatectomy for Prostates Greater than 100 Grams: 5-Year Follow-Up Results of a Randomised Clinical TrialEuropean Urology, 2008
- Holmium Laser Enucleation of the Prostate (HoLEP): Long-Term Results, Reoperation Rate, and Possible Impact of the Learning CurveEuropean Urology, 2007
- Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young MenJournal of Urology, 2007
- HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR MEN WITH URINARY RETENTIONJournal of Urology, 2005
- Change in Serum Prostate Specific Antigen Concentration after Holmium Laser Enucleation of the Prostate: A Marker for Completeness of Adenoma Resection?Journal of Endourology, 2005
- Prostate-specific antigen change in the european randomized study of screening for prostate cancer, section rotterdamUrology, 2004
- PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/mlUrology, 2002
- Prostate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophyProstate Cancer and Prostatic Diseases, 2000
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992